Shortage warning
Current supply issues
High shortage warning
Healthcare professionals should be aware of the potential for delayed onset of angioedema and the distinction between bradykinin- and histamine-mediated cases, as treatment strategies differ significantly and bradykinin-medi…
Affected areas: UK
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 24 studies.
Reviews & meta-analyses: 2 · 2017–2025
Showing all 24 studies, sorted by most relevant.
Gan Ye, Yulong Gu, Wei Zhou, et al.
ACS Catalysis, 2020
Wei‐Ting Lee, Yu-Tang Tung, Chunhao Wu, et al.
Journal of agricultural and food chemistry, 2018
- Gastrointestinal Microbiome
- Bacteria
- Colitis
Yulian Zhu, Chunwei Du, Fan Jiang, et al.
International journal of biological macromolecules, 2024
- Curcumin
- Emulsions
- Starch
Shuli Zhao, Simeng Wang, Qianru Lu, et al.
Food chemistry, 2024
- Calcium Chloride
- Cooking
- Solanum tuberosum
Mohamed U. Nooman, A. Al-kashef, M. Rashad, et al.
The Journal of pharmacy and pharmacology, 2023
- Colitis
- Colitis, Ulcerative
- Yarrowia
Lukas Burgstaller, L. Oliver, T. Dietrich, et al.
Applied Sciences, 2023
Volatile fatty acids can be used as a cheap carbon source for biotechnological lipid production with oleaginous yeasts, but one factor limiting their large-scale use is their inherent cytotoxicity. Developing a suitable cultivation strategy can help mitigate the adverse effect volatile fatty acids have, since these effects are strongly dependent on concentration and pH. This work shows that, by employing a pH-stat fed-batch approach for the cultivation of Apiotrichum brassicae V134 and Pichia kudriavzevii V194, lipid contents above 56 g/100 g dry cell weight and dry cell weight concentrations above 30 g/L can be reached. Furthermore, volumetric lipid productivities up to 0.29 g/Lh could be achieved using acetic and propionic acid as a sole carbon source. It was also demonstrated that the developed process is robust and scalable. Scale-up to the 500 L scale resulted in a similar lipid yield, dry cell weight (31–37 g/L), and single cell oil content (56 g/100 g dry cell weight–58 g/100 g dry cell weight). The main fatty acid present in the produced lipids was oleic acid (36–43%), but also odd-numbered fatty acids, especially heptadecanoic acid (7–15%), were present. Additionally, different methods for the pretreatment of biomass prior to lipid extraction were assessed, and the iodine value (48), peroxide value (7.3), and acid value (4.3) of the extracted single cell oil were determined.
Abstract licence: CC BY
Mîrza CM, Mîrza TV, Odagiu ACM, et al.
2024
- Antioxidants
- Inflammation
- Plant Extracts
Prunella vulgaris (PV) is one of the most commonly used nutraceuticals as it has been proven to have anti-inflammatory and antioxidant properties. The aim of this study was to evaluate the phytochemical composition of PV and its in vivo antioxidant properties. A phytochemical analysis measuring the total phenolic content (TPC), the identification of phenolic compounds by HPLC-DAD-ESI, and the evaluation of the in vitro antioxidant activity by the DPPH assay of the extract were performed. The antioxidant effects on inflammation induced by turpentine oil were experimentally tested in rats. Seven groups with six animals each were used: a control group, the experimental inflammation treatment group, the experimental inflammation and diclofenac sodium (DS) treatment group, and four groups with their inflammation treated using different dilutions of the extract. Serum redox balance was assessed based on total oxidative status (TOS), nitric oxide (NO), malondialdehyde (MDA), total antioxidant capacity (TAC), total thiols, and an oxidative stress index (OSI) contents. The TPC was 0.28 mg gallic acid equivalents (GAE)/mL extract, while specific representatives were represented by caffeic acid, p-coumaric acid, dihydroxybenzoic acid, gentisic acid, protocatechuic acid, rosmarinic acid, vanillic acid, apigenin–glucuronide, hesperidin, kaempferol–glucuronide. The highest amount (370.45 μg/mL) was reported for hesperidin, which is a phenolic compound belonging to the flavanone subclass. The antioxidant activity of the extracts, determined using the DPPH assay, was 27.52 mmol Trolox/mL extract. The PV treatment reduced the oxidative stress by lowering the TOS, OSI, NO, and MDA and by increasing the TAC and thiols. In acute inflammation, treatment with the PV extract reduced oxidative stress, with lower concentrations being more efficient and having a better effect than DS.
Abstract licence: CC BY
Chenlong Liu, Sha Li, Dong chen, et al.
International Journal of Hydrogen Energy, 2019
Shihyu Chuang, M. Ghoshal, L. McLandsborough
Microbiology Spectrum, 2023
- Food Microbiology
- Acetic Acid
- Emulsions
Aqueous-based cleaning and sanitation are undesirable in processing facilities that manufacture low-moisture foods such as peanut butter and chocolate. Alcohol-based sanitization is advantageous because it leaves no residue on the contact surface but requires the processing facility to close temporarily due to flammability. At >6.52 log kill of desiccated Salmonella and Listeria monocytogenes cells, the developed oil-based formulation has the potential to be an effective dry sanitation method.
Abstract licence: CC BY
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.